Algert Global’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Buy
264,200
+141,011
+114% +$6.5M 0.23% 115
2025
Q4
$5.52M Buy
123,189
+68,934
+127% +$2.9M 0.09% 396
2025
Q3
$2.18M Sell
54,255
-48,090
-47% -$1.69M 0.04% 657
2025
Q2
$3.2M Sell
102,345
-21,070
-17% -$687K 0.07% 473
2025
Q1
$4.14M Sell
123,415
-118,002
-49% -$4.48M 0.1% 336
2024
Q4
$9.46M Buy
241,417
+21,772
+10% +$900K 0.22% 123
2024
Q3
$8.65M Buy
219,645
+36,440
+20% +$1.47M 0.23% 107
2024
Q2
$7.14M Sell
183,205
-810
-0.4% -$32.4K 0.24% 102
2024
Q1
$7.92M Sell
184,015
-33,305
-15% -$1.53M 0.31% 65
2023
Q4
$10M Buy
217,320
+88,833
+69% +$3.14M 0.4% 25
2023
Q3
$4.39M Sell
128,487
-16,390
-11% -$613K 0.21% 144
2023
Q2
$5.58M Buy
144,877
+106,470
+277% +$4.23M 0.24% 93
2023
Q1
$1.38M Buy
38,407
+1,991
+5% +$73.6K 0.06% 501
2022
Q4
$1.44M Sell
36,416
-8,830
-20% -$322K 0.08% 419
2022
Q3
$1.63M Buy
45,246
+18,842
+71% +$677K 0.1% 344
2022
Q2
$803K Buy
26,404
+14,330
+119% +$433K 0.06% 567
2022
Q1
$369K Buy
+12,074
New +$361K 0.02% 911

Other funds holding XENE